Prof. Helena Danielson is Professor of Biochemistry at Uppsala University in Sweden since 2002. She is a specialist in enzyme-based drug discovery and molecular recognition. Her basic education includes a Master of Science in Chemical Engineering at Lund University in 1982 followed by a Master of Science in Biochemistry, University of Rochester, Rochester, NY, USA in 1984, carried out as a Fulbright scholar. She returned to Sweden and obtained a Ph. D. in Biochemistry at Stockholm University in 1987. As a postdoc at Karolinska Institutet in Stockholm Helena Danielson started a research project on HIV protease as a drug target for AIDS, and has since then expanded her research to other enzymes and diseases, more recently also with an interest in membrane receptors, ion channels, protein-protein interactions, cell signaling and neurological function. Helena Danielson has focused on developing enzymology for drug discovery, and in particular SPR-biosensor based biomolecular interaction analysis for detailed studies of enzyme-inhibitor interactions and other important recognition processes in the life science area. Helena Danielson co-founded Beactica AB in 2006 and was Chief Scientific Officer until 2014. Now she is on the She has held many administrative positions at Uppsala University, and was the Dean of the Faculty of Science and Technology 2011-2014. At present, she is head of the Department of Chemistry – BMC.